Seyahatten Sonra Ateş

Brunette GW, & Center for Disease Control. (2015). CDC health information for international travel 2016: The yellow book. Edinburgh: Mosby

Freedman DO, Weld LH, Kozarsky PE et al. Spectrum of Disease and relation to place of exposure among ill returned travelers, N Engl J Med 32006;354(2):119-30.

Wilson ME, Weld LH, Boggild A, et al. Fever in returned travelers: results from the GeoSentinel Surveillance Network. Clin Infect Dis. 2007;44(12):1560-1568. doi:10.1086/518173

Charrel RN, de Lamballerie X, Raoult D. Chikungunya outbreaks--the globalization of vectorborne diseases. N Engl J Med. 2007;356(8):769-771. doi:10.1056/NEJMp078013

Bottieau E, Clerinx J, Van den Enden E et al. Infectious mononucleosis-like syndromes in febrile travelers returning from thetropics, J Travel Med 2006;13(4):191-7.

Bottieau E, Clerinx J, Schrooten W et al. Etiology and outcome of fever after a stay in thetropics, Arch Intern Med 2006;166(15):1642-8.

Chen N, Auliff A, Rieckmann K, Gatton M, Cheng Q. Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. J Infect Dis. 2007;195(7):934-941. doi:10.1086/512242

Imwong M, Snounou G, Pukrittayakamee S, et al. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J Infect Dis. 2007;195(7):927-933. doi:10.1086/512241

Wilson ME, Freedman DO. Etiology of travel-related fever. Curr Opin Infect Dis. 2007;20(5):449-453. doi:10.1097/QCO.0b013e3282a95e27

Hill DR, Ericsson CD, Pearson RD, et al. The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43(12):1499-1539. doi:10.1086/508782

Hagmann SH, Han PV, Stauffer WM, et al. Travel-associated disease among US residents visiting US GeoSentinel clinics after return from international travel. Fam Pract. 2014;31(6):678-687. doi:10.1093/fampra/cmu063

Mendelson M, Han PV, Vincent P, et al. Regional variation in travel-related illness acquired in Africa, March 1997-May 2011. Emerg Infect Dis. 2014;20(4):532-541. doi:10.3201/eid2004.131128

de Souza WM, de Lima ST, Mello LMS et al. Spatiotemporal dynamics and recurrence of chikungunya virus in Brazil: an epidemiological study. The Lancet Microbe 4.5 (2023): e319-e329.

Grabenstein JD, Tomar AS. Global geotemporal distribution of chikungunya disease, 2011-2022. Travel Med Infect Dis. 2023;54:102603. doi:10.1016/j.tmaid.2023.102603

Nsoesie EO, Kraemer MU, Golding N, et al. Global distribution and environmental suitability for chikungunya virus, 1952 to 2015. Euro Surveill. 2016;21(20):10.2807/1560-7917.ES.2016.21.20.30234. doi:10.2807/1560-7917.ES.2016.21.20.30234

Nitatpattana N, Kanjanopas K, Yoksan S, et al. Long-term persistence of Chikungunya virus neutralizing antibodies in human populations of North Eastern Thailand. Virol J. 2014;11:183. Published 2014 Oct 21. doi:10.1186/1743-422X-11-183

Gérardin P, Guernier V, Perrau J, et al. Estimating Chikungunya prevalence in La Réunion Island outbreak by serosurveys: two methods for two critical times of the epidemic. BMC Infect Dis. 2008;8:99. Published 2008 Jul 28. doi:10.1186/1471-2334-8-99

Simon F, Javelle E, Oliver M, Leparc-Goffart I, Marimoutou C. Chikungunya virus infection. Curr Infect Dis Rep. 2011;13(3):218-228. doi:10.1007/s11908-011-0180-1

Coffey, L. L., Failloux, A. B., & Weaver, S. C. Chikungunya virus–vector interactions. Viruses, 2014;6(11), 4628-4663.

Guzman, Maria G., and Eva Harris. "Dengue." The Lancet 385.9966 (2015): 453-465.

Kularatne SA. Dengue fever. BMJ. 2015;351:h4661. Published 2015 Sep 15. doi:10.1136/bmj.h4661

Wu JY, Lun ZR, James AA, Chen XG. Dengue Fever in mainland China. Am J Trop Med Hyg. 2010;83(3):664-671. doi:10.4269/ajtmh.2010.09-0755

Schaefer TJ, Panda PK, Wolford RW. Dengue Fever. In: StatPearls. Treasure Island (FL): StatPearls Publishing; March 6, 2024.

Dengue Fever world wide: an overview of the current situation and the implications for Europe Diseases of Environmental and Zoonotic Origin Team (ezo@ecdc.europa.eu) European Center for Disease Prevention and Control, Stockholm, Sweden Refik Saydam Hygiene Center Presidency, Epidemic Diseases Research Directorate Turkish Hygiene Den. Biol. Journal. 2007; 64 (3) Epidemiology Report 3

Kumar, K. J., Meghana, M., Jagwani, H., & Reddy, H. Deng Enfeksiyonunda Eş Zamanlı Staphylococcus aureus Septisemi ve Septik Artrit. Cocuk Enfeksiyon Dergisi, 2019;13(4), 206-209.

Ana Belén Araúz MD, MSc, DTM & H. Padmasayee Papineni North American Infectious Disease Clinics Histoplasmosis BSc, MBBS, MRCP, Dip HIV, DMCC, DTM & H b 1 Volume 35, Issue 2, June 2021, Pages 471-491. https://doi.org/10.1016/j.idc.2021.03.011

Tobón AM, Gómez BL. Pulmonary Histoplasmosis. Mycopathologia. 2021;186(5):697-705. doi:10.1007/s11046-021-00588-4

Adderson E. Histoplasmosis. Pediatr Infect Dis J. 2006;25(1):73-74. doi:10.1097/01.inf.0000196922.46347.66

Azar MM, Loyd JL, Relich RF, Wheat LJ, Hage CA. Current Concepts in the Epidemiology, Diagnosis, and Management of Histoplasmosis Syndromes. Semin Respir Crit Care Med. 2020;41(1):13-30. doi:10.1055/s-0039-1698429

Oladele RO, Ayanlowo OO, Richardson MD, Denning DW. Histoplasmosis in Africa: An emerging or a neglected disease?. PLoS Negl Trop Dis. 2018;12(1):e0006046. Published 2018 Jan 18. doi:10.1371/journal.pntd.0006046

Ekeng BE, Davies AA, Osaigbovo II, et al. Current epidemiology of histoplasmosis in Nigeria: A systematic review and meta-analysis. Niger Postgrad Med J. 2023;30(1):12-17. doi:10.4103/npmj.npmj_311_22

Potosí JA, Gutiérrez YM, González FE. The relevance of clinical and epidemiological correlation in the early diagnosis of histoplasmosis: report of two clinical cases in Popayán, Colombia. La importancia de la correlación clínico-epidemiológica en el diagnóstico temprano de la histoplasmosis: reporte de dos casos clínicos en Popayán, Colombia. Biomedica. 2023;43(Sp. 1):20-31. Published 2023 Aug 31. doi:10.7705/biomedica.6782

Özbilgin, A., İbrahim Çavuş, A. N., & Özel, Y. The Production of Trypanosoma Brucei Rhodesiense, Cause of African Sleeping Sickness, and Trypanosoma Cruzi, Cause of American Chagas Disease, on Different Medias and Testing a New Media. Turkiye Parazitol Derg. 2020;44(1),7-11.

Eperon G, Balasegaram M, Potet J, Mowbray C, Valverde O, Chappuis F. Treatment options for second-stage gambiense human African trypanosomiasis. Expert Rev Anti Infect Ther. 2014;12(11):1407-1417. doi:10.1586/14787210.2014.959496

Bottieau E, Clerinx J. Human African Trypanosomiasis: Progress and Stagnation. Infect Dis Clin North Am. 2019;33(1):61-77. doi:10.1016/j.idc.2018.10.003

Liu Q, Zhou XN. Preventing the transmission of American trypanosomiasis and its spread into non-endemic countries. Infect Dis Poverty. 2015;4:60. Published 2015 Dec 28. doi:10.1186/s40249-015-0092-7

Carod-Artal FJ. Trypanosomiasis, cardiomyopathy and the risk of ischemic stroke. Expert Rev Cardiovasc Ther. 2010;8(5):717-728. doi:10.1586/erc.10.33

Chimelli L, Scaravilli F. Trypanosomiasis. Brain Pathol. 1997;7(1):599-611. doi:10.1111/j.1750-3639.1997.tb01077.x

Karakavuk M, Aykur M, Ünver A, Döşkaya M. Parasitic Diseases that can Infect Travelers to Africa. Turkiye Parazitol Derg. 2018;42(2):154-160. doi:10.5152/tpd.2018.5256

Bays DJ, Thompson GR 3rd. Coccidioidomycosis. Infect Dis Clin North Am. 2021;35(2):453-469. doi:10.1016/j.idc.2021.03.010

Kirkland TN, Fierer J. Coccidioides immitis and posadasii; A review of their biology, genomics, pathogenesis, and host immunity. Virulence. 2018;9(1):1426-1435. doi:10.1080/21505594.2018.1509667

Johnson RH, Sharma R, Kuran R, Fong I, Heidari A. Coccidioidomycosis: a review [published correction appears in J Investig Med. 2021 Dec;69(8):1486. doi: 10.1136/jim-2020-001655corr1.]. J Investig Med. 2021;69(2):316-323. doi:10.1136/jim-2020-001655

Hartmann CA, Aye WT, Blair JE. Treatment considerations in pulmonary coccidioidomycosis. Expert Rev Respir Med. 2016;10(10):1079-1091. doi:10.1080/17476348.2017.1234378

Musso D, Gubler DJ. Zika Virus. Clin Microbiol Rev. 2016;29(3):487-524. doi:10.1128/CMR.00072-15

Ferraris P, Yssel H, Missé D. Zika virus infection: an update. Microbes Infect. 2019;21(8-9):353-360. doi:10.1016/j.micinf.2019.04.005

Duong, V., Dussart, P., Buchy, P. Zika virus in Asia. International Journal of Infectious Diseases. 2017;54:121-128.

Sharma S, Tandel K, Dash PK, Parida M. Zika virus: A public health threat. J Med Virol. 2017;89(10):1693-1699. doi:10.1002/jmv.24822

Buerano CC, Pangilinan LS, Dimamay MTA, et al. Zika Virus Infection, Philippines, 2012. Emerg Infect Dis. 2020;26(9):2300-2301. doi:10.3201/eid2609.190896

Biswas A, Kodan P, Gupta N, et al. Zika outbreak in India in 2018. J Travel Med. 2020;27(4):taaa001. doi:10.1093/jtm/taaa001

Pacenti M, Sinigaglia A, Franchin E, et al. Human West Nile Virus Lineage 2 Infection: Epidemiological, Clinical, and Virological Findings. Viruses. 2020;12(4):458. Published 2020 Apr 18. doi:10.3390/v12040458

Rajaiah P, Mayilsamy M, Kumar A. West Nile virus in India: An update on its genetic lineages. J Vector Borne Dis. 2023;60(3):225-237. doi:10.4103/0972-9062.374039

Snyder RE, Cooksey GS, Kramer V, Jain S, Vugia DJ. West Nile Virus-Associated Hospitalizations, California, 2004-2017. Clin Infect Dis. 2021;73(3):441-447. doi:10.1093/cid/ciaa749

Camp JV, Nowotny N. The knowns and unknowns of West Nile virus in Europe: what did we learn from the 2018 outbreak?. Expert Rev Anti Infect Ther. 2020;18(2):145-154. doi:10.1080/14787210.2020.1713751

Sinigaglia A, Peta E, Riccetti S, Barzon L. New avenues for therapeutic discovery against West Nile virus. Expert Opin Drug Discov. 2020;15(3):333-348. doi:10.1080/17460441.2020.1714586

Fiacre L, Pagès N, Albina E, Richardson J, Lecollinet S, Gonzalez G. Molecular Determinants of West Nile Virus Virulence and Pathogenesis in Vertebrate and Invertebrate Hosts. Int J Mol Sci. 2020;21(23):9117. Published 2020 Nov 30. doi:10.3390/ijms21239117

Pham D, Howard-Jones AR, Hueston L, et al. Emergence of Japanese encephalitis in Australia: a diagnostic perspective. Pathology. 2022;54(6):669-677. doi:10.1016/j.pathol.2022.07.001

Kumar A, Sharma P, Shukla KK, Misra S, Nyati KK. Japanese encephalitis virus: Associated immune response and recent progress in vaccine development. Microb Pathog. 2019;136:103678. doi:10.1016/j.micpath.2019.103678